Volume 26, Issue 1 e14129
BRIEF COMMUNICATION
Free to Read

Eligible neonatal donors after circulatory determination of death (Maastricht type III): A national survey of level III NICUs

Sonia Caserío

Corresponding Author

Sonia Caserío

Neonatology, Hospital Universitario Rio Hortega de Valladolid, Valladolid, Spain

NeNe Foundation, Madrid, Spain

Correspondence

Sonia Caserío, Hospital Universitario Rio Hortega de Valladolid, C/Dulzaina Nº2, 47012 Valladolid, Spain.

Email: [email protected]

Search for more papers by this author
Juan Arnaez

Juan Arnaez

NeNe Foundation, Madrid, Spain

Neonatology, Complejo Universitario de Burgos, Burgos, Spain

Search for more papers by this author
on behalf of the Neo-Spain Donation Group

the Neo-Spain Donation Group

Search for more papers by this author
First published: 02 September 2021
Citations: 5

The members of Neo-Spain Donation Group is in Appendix section.

Funding information

The authors did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Abstract

Background

Organ donation continues to increase worldwide, but in general paediatric patients remain less likely to receive a transplant. The inclusion of neonates as donors after cDCD should be considered in an effort to increase donation rates.

Methods

The survey for a cross-sectional national study of potential cDCD neonatal donors (Maastricht type III) was sent to all 90 level III Spanish neonatal units to explore: 1) protocols, education, and specific opinions on donation and 2) potential cDCD that could have been eligible over a 2-year period (2014–2015).

Results

Forty-five centers (50%) completed the survey, and 38/45 gave information about potential eligible donors. In 16% of the centers specific protocols on neonatal donation exist. All hospitals demanded more specific training, and 65% noted that the donation process could be a problem in the family's dismissal of the child.

During the study period 46 805 neonates were admitted in the 38 centers, and 625 neonates died. Ninety-five born at a gestational age ≥34 weeks and above 2000 gr died after an EoL decision, 38 (40%) and 13 (14%) of them due to neonatal encephalopathy and multiple congenital anomalies, respectively. There were 31 (33%) elegible infants who died in less than 120 min due to pathologies that did not contraindicate donation.

Conclusions

Neonatal cDCD could help to reduce the gap between the supply of and demand for organs according to the potentially eligible patients emerging from this study. Training in EoL and donation processes should be provided to healthcare professionals.

CONFLICT OF INTEREST

The authors report no conflict of interest.

DATA AVAILABILITY STATEMENT

The authors confirm that the data supporting the findings of this study are available within the article and its Supplementary materials. Any other information is available on reasonable request from the corresponding author.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.